iRhythm Holdings, Inc. is a digital healthcare company that designs, develops, and commercializes device-based technology for ambulatory cardiac monitoring. The company provides services to detect, predict, and prevent cardiac arrhythmias, primarily atrial fibrillation, through the iRhythm ACM System. This system combines a wire-free, patch-based wearable biosensor that continuously records electrocardiogram data with proprietary cloud-based data analytic software. The company offers long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry services via Medicare-enrolled independent diagnostic testing facilities. iRhythm serves physicians and patients in the United States, the European Union, Switzerland, and the United Kingdom, with operations in the Philippines. The company was formerly known as iRhythm Technologies and was incorporated in 2006. It acquired VitalConnect, which is now part of the iRhythm portfolio. The company’s technology is FDA-cleared, CE-marked, and approved by the Japan Pharmaceuticals and Medical Devices Agency.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Devices Homepage irhythmtech.com
Sector Healthcare IR page investors.irhythmtech.com/overview/default.aspx
Tags
cardiac monitoring, arrhythmia detection, wearable biosensors, electrocardiogram, atrial fibrillation, cloud analytics, digital health, diagnostic testing, iRhythm ACM System, Zio ECG monitors, Zio AT, MyZio, ZioSuite, VitalConnect, iRhythm Technologies Ltd.
Press page —

Metrics

Valuation  
Market cap $ 3.772B
Market cap (USD) $ 3.772B
P/E -97.98
PEG —
P/BV 21.30
P/S 4.42
P/OCF 67.89
P/FCF 511.02
Dividend yield —
Turnover / mcap —
Returns  
ROE -36.6%
ROI -5.6%
ROIC -5.4%
Profit margin -6.0%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 425.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 36
Quality score -5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Revenue 747.138M 591.839M 492.681M 410.921M 322.825M 265.166M 214.552M 147.293M 98.509M 64.072M 36.14M
Net profit -44.551M -113.289M -123.406M -116.155M -101.361M -43.83M -54.568M -48.28M -29.42M -20.903M -22.799M
Free cash flow 34.521M -30.552M -90.525M -52.842M -65.82M -27.31M -42.32M -34.248M -18.473M -19.414M -19.792M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Share price 177.44 90.17 107.04 93.67 117.69 237.21 68.09 69.48 56.05 30 —
Price performance 12m 0.97 -0.16 0.14 -0.2 -0.5 2.48 -0.02 0.24 0.87 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 9.41M 13M 22M 23.9M 29.9M 46.4M 49.9M 61.5M 79.9M 75.7M
↳ YoY growth +68.7% +37.7% +69.7% +8.6% +25.4% +55.1% +7.5% +23.2% +30.0% -5.3%
↳ 5y CAGR +39.9% +37.6% +31.0% +22.8% +27.3% +20.4%
Borrowings, current (USD) — 1.49M 0.00 1.94M 11.7M 11.7M 0.00 — — —
Borrowings, non-current (USD) 32.2M 32.5M 34.9M 33M 21.3M 9.69M 34.9M 35M — —
Lease liabilities (USD) — — 0.00 85.7M 81.3M 96.4M 96.1M 94.9M 90.5M 81.7M
Cash and deposits (USD) 51.6M 8.67M 20M 20.5M 88.6M 128M 78.8M 36.2M 420M 236M
Right-of-use assets (USD) — — 0.00 90.1M 84.7M 84.6M 60.7M 49.3M 47.6M 41.8M
Net debt (borrowings + leases - cash) (USD) -19.4M 25.3M 14.9M 67.2M 4.33M -19.5M 52.2M 93.7M — —
Cash flow detail
Operating cash flow (USD) -16.7M -14.9M -29.1M -21.9M -13.8M -37.8M -23M -50.1M 3.39M 80.9M
Purchases of property, plant and equipment (USD) -2.76M -3.56M -5.18M -20.5M -13.6M -28.1M -29.8M -40.4M -33.9M -46.3M
Change in receivables (cash effect) (USD) -8.52M -13M -22.9M -28.7M -38M -53.6M -61.8M -81.2M -91.9M -95.4M
Change in inventories (cash effect) (USD) -245,000 -293,000 -380,000 -1.97M -1.39M -4.96M -5.11M 979,000 -224,000 -8.51M
Change in payables (cash effect) (USD) 305,000 634,000 -192,000 5.6M -3.88M 6.14M -2.99M -1.97M -7.41M 28M
Share buybacks (cash effect) (USD) — — — — — — 0.00 0.00 -25M 0.00
Interest paid (cash effect) (USD) -1.59M -1.55M -6.07M -1.64M -1.5M -1.19M -3.32M -2.96M -6.39M -9.92M
Income taxes paid (cash effect) (USD) — — — — 0.00 0.00 -287,000 -1.13M -923,000 -1.2M
Share-based compensation (USD) 1.87M 10.1M 16.3M 26.2M 41.5M 54.5M 57.7M 77.2M 76M 88.3M
Operating cash flow before change in receivables (USD) -8.14M -1.96M -6.18M 6.86M 24.2M 15.8M 38.8M 31.1M 95.3M 176M
Free cash flow (OCF - PPE - intangibles) (USD) -19.4M -18.5M -34.2M -42.3M -27.3M -65.8M -52.8M -90.5M -30.6M 34.5M
Income detail
Research and development expense (USD) 7.15M 13.3M 20.8M 37.3M 41.3M 38.7M 46.6M 60.2M 71.5M 84.6M
↳ 5y CAGR +45.6% +45.4% +40.2% +28.4% +23.8% +13.9% +15.4%
Total comprehensive income (USD) -20.9M -29.5M -48.3M -54.5M -43.9M -101M -116M -123M -113M -44.3M
Comprehensive income to owners (USD) -20.9M -29.5M -48.3M -54.5M -43.9M -101M -116M -123M -113M -44.3M
Provision for credit losses (USD) 1.96M 3.64M 5.83M 9.13M 10.5M 9.62M 17.2M 17.1M 22.6M 30.8M
Credit cost ratio (credit losses / average receivables) (%) 26.2% 32.6% 33.4% 39.8% 39.1% 25.2% 35.7% 30.7% 31.9% 39.6%
Reported Mar 31, 2017 Mar 1, 2018 Mar 2, 2020 May 8, 2020 Feb 23, 2023 Feb 23, 2023 Feb 20, 2025 Feb 20, 2025 Feb 20, 2025 Feb 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

iRhythm Holdings, Inc. — Regulation FD Disclosure Bull 3 Bear 0 Capital return

On November 17, 2026, iRhythm Holdings, Inc., a Delaware corporation (the “Company”), issued a press release announcing its entry into the accelerated share repurchase agreement described under Item 8.01 below. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Other Events

On November 17, 2026, the Company entered into an accelerated share repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPMorgan”) to repurchase an aggregate of $100.0 million of the Company’s common stock, par value $0.001 per share (“Common Stock” and such transaction, the “ASR Transaction”). The ASR Transaction is being made under the Company’s previously announced share repurchase program, pursuant to which the Company’s board of directors authorized the repurchase of up to $200.0 million of Common Stock, as disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on November 12, 2026.

On November 11, 2026, the Board of Directors (the “Board”) of iRhythm Holdings, Inc. (the “Company”) adopted the iRhythm Deferred Compensation Plan (the “Plan”), to be sponsored by the Company and providing for participation by the Company’s wholly owned subsidiaries, iRhythm Technologies, Inc. and Vital Connect, Inc., with an effective date of January 1, 2027.

The Plan is a nonqualified deferred compensation plan that allows eligible employees and non-employee directors to defer receipt of taxable income and thereby defer income taxes and assist in saving for retirement. Under the Plan, each eligible employee, which includes the Company’s named executive officers, is permitted to elect to defer receipt of up to 80% of such employee’s base salary and up to 100% of such employee’s annual bonus, and each eligible non-employee director is permitted to elect to defer receipt of up to 100% of such director’s cash fees.

SAN FRANCISCO, November 11, 2026 - iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November 10, 2026, its Board of Directors approved a share repurchase program with authorization to purchase up to $200 million of the company’s outstanding common stock.

The approval reflects iRhythm’s confidence in the continued strength of its core business, as well as its significant new growth opportunities from the addition of the recently acquired VitalConnect business.

Repurchases under the program may be made in the open market, in privately negotiated transactions, through accelerated share repurchase transactions or by other methods, with the amount and timing of repurchases to be determined at the company’s discretion, depending on market conditions and corporate needs. Open market repurchases will be structured to occur in accordance with applicable federal and state securities laws, including within the pricing and volume conditions of Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Prompts

iRhythm Holdings, Inc. (ticker IRTC), listed in United States.

Company History

Date Change Detail
Jan 12, 2026 Renamed IRHYTHM TECHNOLOGIES, INC. → IRHYTHM HOLDINGS, INC.

ETFs Holding iRhythm Holdings, Inc.

ETF Weight in ETF Shares Market value As of
LGHT 2.39% 497 $ 59.118K Jun 30, 2026
MEDI 1.00% 4,641 $ 434.212K Nov 12, 2026
FFOX 0.99% 20,078 $ 2.388M Jun 30, 2026
GSC 0.81% 18,946 $ 2.253M Aug 31, 2026
FMED 0.80% 3,471 $ 412.841K Aug 31, 2026
MMSC 0.57% 3,138 $ 285.025K Nov 16, 2026
FSML 0.48% 5,027 $ 597.962K Jun 30, 2026
SCDS 0.32% 323 $ 28.962K Nov 17, 2026
MSSM 0.31% 18,400 $ 2.188M Aug 31, 2026
ESSC 0.30% 913 $ 106.976K Jul 31, 2026
PSC 0.29% 56,554 $ 6.727M Jun 30, 2026
FSEG 0.28% 136 $ 16.177K Jun 30, 2026
RESM 0.18% 55 $ 6,542.25 Jun 30, 2026
AVSC 0.15% 50,973 $ 4.63M Nov 16, 2026
FSCC 0.14% 4,204 $ 500.024K Aug 31, 2026
FESM 0.01% 5,271 $ 626.985K Jun 30, 2026
IALT short -0.01% -7,714 $ -700.663K Nov 16, 2026
DFAS 0.01% 18,013 $ 1.685M Nov 12, 2026
DXUV 0.00% 70 $ 6,549.20 Nov 12, 2026
NTRL 0.00% 1,107 $ 0.00 Nov 16, 2026